Article Details

GentiBio Nets $157M to Restore Immune Tolerance With Tregs

Retrieved on: 2021-08-11 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

GentiBio Nets $157M to Restore Immune Tolerance With Tregs. View article details on hiswai:

Excerpt

So Cambridge, Massachusetts-based Genti is combining Tregs biology and antigen receptor engineering to create potently engineered Tregs, ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up